杆菌病毒性基因在致病性和疫苗开发中的关键作用
Ayman Elbehiry1, Eman Marzouk1, Adil Abalkhail1
1Department of Public Health, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
Frontiers in medicine
|January 24, 2025
概括
杆菌 (H. pylori) 的抗生素耐药性需要新的治疗方法. 针对H. pylori毒性因子的疫苗为感染控制和预防提供了一个有希望的策略,尽管对人类的有效性需要进一步研究.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 杆菌 (H. pylori) 是一种广泛的细菌感染,影响全球一半以上的人口.
- 对H. pylori的抗生素耐药性是一个越来越令人担忧的问题,限制了治疗疗效.
- 只有很小一部分感染者会患上严重的胃肠疾病,这表明宿主-病原体相互作用是关键.
研究的目的:
- 提供对H. pylori感染的全面审查,重点关注毒性因素,疾病机制和疫苗开发.
- 评估目前针对H. pylori的疫苗接种策略,包括各种疫苗类型及其临床前/临床进展.
- 突出针对H. pylori毒性因子对于有效的疫苗设计的重要性.
主要方法:
- 对H. pylori毒性因子 (例如,CagA,VacA,OMPs,NAP,尿素酶,催化酶) 的文献综述.
- 在动物模型和人体试验中测试的不同疫苗接种策略和配方的分析.
- 对H. pylori病毒性基因和疫苗疗效的最新研究的评估.
主要成果:
- 已经确定了几种H. pylori病毒性因素作为潜在的疫苗点.
- 各种疫苗平台 (基于载体的,全细胞的,亚单元的,DNA的) 在动物模型中显示出前景.
- 在人体试验中取得了有限的成功,有效性和可重复性仍然不确定.
结论:
- 针对H. pylori毒性因子的疫苗是抗生素的潜在替代品.
- 需要进一步的研究来开发有效和可重复的疫苗来治疗H. pylori感染.
- 解决与H. pylori相关的疾病需要创新的策略,超越传统的抗生素治疗.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
535
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
535
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
324
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
324
Lysogenic Cycle of Bacteriophages
61.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.8K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
349
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
349
Cancer Vaccines
332
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
332
Vaccinations
43.9K
Overview
43.9K


